methyl thiocyanate : A member of the class of thiocyanates that is the methyl ester of thiocyanic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 11168 |
| CHEBI ID | 61112 |
| MeSH ID | M0136981 |
| Synonym |
|---|
| mescn |
| CHEBI:61112 |
| ch3scn |
| methyl thiocyanide |
| wln: ncs1 |
| methyl thiocyanate |
| methyl sulfocyanate |
| nsc9368 |
| 556-64-9 |
| thiocyanic acid, methyl ester |
| methane, thiocyanato- |
| methylrhodanid |
| nsc-9368 |
| inchi=1/c2h3ns/c1-4-2-3/h1h |
| thiocyanic acid,methyl ester |
| einecs 209-134-6 |
| hsdb 5691 |
| methylrhodanid [german] |
| methylthiokyanat [czech] |
| brn 1098357 |
| ai3-16178 |
| methyl rhodanate |
| nsc 9368 |
| FT-0695131 |
| T0201 |
| thiocyanic acid methyl ester |
| methyl rhodanide |
| AKOS009158012 |
| unii-55i23vy6ie |
| methylthiokyanat |
| 4-03-00-00327 (beilstein handbook reference) |
| 55i23vy6ie , |
| methyl thiocyanate [hsdb] |
| methyl thiocyanate [mi] |
| thiocyanatomethane |
| CS-M0697 |
| methylthiocyanate |
| methylthiocyanide |
| DTXSID5060304 |
| methyl thiocyanate, 97% |
| mfcd00001830 |
| Q5928515 |
| cyanomethyl thioether |
| (methylsulfanyl)carbonitrile |
| EN300-43044 |
| Class | Description |
|---|---|
| thiocyanates | Esters of thiocyanic acid with general formula RSC#N. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Pathway | Proteins | Compounds |
|---|---|---|
| sulfur volatiles biosynthesis | 2 | 6 |
| sulfur volatiles biosynthesis | 2 | 5 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (35.65) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||